Victory Capital Management
COGT icon

Victory Capital Management’s Cogent Biosciences COGT Stock Holding History

Victory Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21M Buy
109,419
+57,833
+112% +$2.14M ﹤0.01% 1381
2025
Q4 		$1.83M Buy
51,586
+38,632
+298% +$1.09M ﹤0.01% 1606
2025
Q3 		$186K Buy
12,954
+1,742
+16% +$20.6K ﹤0.01% 2233
2025
Q2 		$80.5K Sell
11,212
-289
-3% -$1.6K ﹤0.01% 2348
2025
Q1 		$68.9K Buy
11,501
+501
+5% +$3.93K ﹤0.01% 2343
2024
Q4 		$85.8K Buy
11,000
+508
+5% +$5.06K ﹤0.01% 2349
2024
Q3 		$113K Buy
+10,492
New +$102K ﹤0.01% 2312
2024
Q2 		– Sell
-11,470
Closed -$77.1K – 2491
2024
Q1 		$77.1K Buy
+11,470
New +$70.9K ﹤0.01% 2331
2020
Q2 		– Sell
-1,266
Closed -$2K – 2675
2020
Q1 		$2K Buy
+1,266
New +$3.52K ﹤0.01% 3630
2019
Q4 		– Sell
-583
Closed -$3K – 2773
2019
Q3 		$3K Buy
+583
New +$4.74K ﹤0.01% 3550
2018
Q2 		– Sell
-62,500
Closed -$2.78M – 1831
2018
Q1 		$2.78M Buy
+62,500
New +$2.78M 0.01% 976

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Victory Capital Management's COGT Position: Q1 2026 in Review

Victory Capital Management increased its Cogent Biosciences (COGT) stake by 112% in Q1 2026, buying an estimated $2.14M and bringing the position to 109,419 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Victory Capital Management first reported a position in COGT in Q1 2018 and has held it in 11 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Victory Capital Management held 109,419 shares of Cogent Biosciences worth $4.21M as of Q1 2026.
  • Victory Capital Management bought 57,833 Cogent Biosciences shares in Q1 2026, an estimated $2.14M.
  • Cogent Biosciences made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #1381 holding.
  • Victory Capital Management first reported a position in Cogent Biosciences in Q1 2018 and has held it in 11 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.